ALBERTI VIOLETTI, SILVIA
ALBERTI VIOLETTI, SILVIA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Clinicopathological definition, management and prognostic value of mogamulizumab‐associated rash and other cutaneous events: A systematic review
2024 G. Avallone, G. Roccuzzo, A. Pileri, C. Agostinelli, C.A. Maronese, C. Aquino, G. Tavoletti, F. Onida, P. Fava, S. Ribero, A.V. Marzano, E. Berti, P. Quaglino, S. Alberti‐violetti
Whole-exome sequencing is feasible on a fresh-frozen skin sample of intravascular large B cell lymphoma
2024 F. Bagnoli, G. Pini, B. Ziccheddu, A. Bonometti, S. Alberti-Violetti, L. Venegoni, G. Isimbaldi, M.C. Da Vià, A. Ferrari, L. Baldini, A. Neri, F. Onida, N. Bolli, E. Berti
The unexpected guest: Cytotoxic, pseudolymphoma-like reaction at the site of primary cutaneous follicle centre B-cell lymphoma in a patient receiving secukinumab for psoriasis
2024 C. Pescia, G. Pini, S. Tabano, E. Berti, S. Alberti Violetti, G.A. Croci
Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis
2024 M. Sciumè, F. Serpenti, R. Zanotti, P. Bonadonna, I. Tanasi, L. Crosera, C. Elena, F. Mannelli, F. Crupi, C. Papayannidis, C. Sartor, S. Soverini, M. Rondoni, C. Eller-Vainicher, V. Pravettoni, F. Rivolta, S. Alberti Violetti, G.A. Croci, A.C. Migliorini, N. Bolli, D. Giannarelli, F.I. Grifoni
Primary cutaneous, epidermotropic mycosis fungoides-like presentation: critical appraisal and description of two novel cases, broadening the spectrum of ALK+ T-cell lymphoma
2024 G.A. Croci, L. Appio, C. Cecchetti, S. Tabano, S. Alberti-Violetti, E. Berti, D. Rahal, F. Cavallaro, F. Onida, D. Tomasini, E. Todisco
Paediatric cutaneous lymphomas including rare subtypes: A 40‐year experience at a tertiary referral centre
2024 S. Alberti‐violetti, G. Avallone, C. Colonna, G. Tavoletti, L. Venegoni, V. Merlo, S. Cambiaghi, A.V. Marzano, E. Berti, R. Cavalli
A Microenvironment-Related Nine-Gene Signature May Predict Survival in Mycosis Fungoides Patients at Diagnosis
2023 S. Alberti-Violetti, M. Rosaria Sapienza, M. Del Corvo, F. Melle, G. Motta, L. Venegoni, L. Cerroni, C. Cota, A. Pileri, E. Berti, S. Pileri
T follicular helper phenotype mycosis fungoides associated with acanthosis nigricans
2023 C.B. Spigariolo, E. Berti, A. Cerri, L. Venegoni, G. Croci, S.A. Violetti
Vitiligo-like lesions induced by cyclin-dependent kinase 4/6 inhibitor palbociclib
2023 M. Romagnuolo, S. Alberti Violetti, D. Riva, F. Barberi, C. Moltrasio
Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study
2023 G. Avallone, C.A. Maronese, G. Murgia, C.G. Carrera, L. Mastorino, G. Roccuzzo, P. Dapavo, S. Alberti-Violetti, P. Quaglino, S. Ribero, A.V. Marzano
Wait and see: a case of EBV + cutaneous extranodal NK/T-type lymphoma with indolent behaviour
2023 I.F. Aromolo, C. Pescia, D. Simeoli, S.A. Violetti, V. Ferla, F.G. Rossi, G.A. Croci
Disseminated superficial actinic porokeratosis following hydroxyurea treatment: A case report
2023 M. Romagnuolo, D. Riva, S. Alberti Violetti, A. Di Benedetto, F. Barberi, C. Moltrasio
Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitals
2022 G. Avallone, C.A. Maronese, C. Conforti, P. Fava, L. Gargiulo, A.V. Marzano, C. Massone, L. Mastorino, A. Paradisi, A. Pileri, P. Quaglino, N. Rizzo, S. Ribero, G. Roccuzzo, G. Tavoletti, C.A. Vignoli, I. Zalaudek, E. Berti, S. Alberti-Violetti
Three cases of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by proton-pump inhibitors
2022 C.B. Spigariolo, F. Barei, C.A. Maronese, F. Barberi, A. Cattaneo, S.A. Violetti
Cutaneous B-cell lymphomas: Update on diagnosis, risk-stratification, and management
2022 P. Fava, G. Roccuzzo, S. Alberti-Violetti, V. Grandi, A. Pileri, N. Pimpinelli, E. Berti, P. Quaglino
Maculopapular rash: An overlooked monkeypox diagnostic clue?
2022 G. Avallone, C.A. Maronese, E. Quattri, G. Roccuzzo, L. Mastorino, S. Alberti-Violetti, S. Ramoni, A. Lucchini, S. Delmonte, P. Quaglino, A.V. Marzano, S. Ribero
An expert consensus report on mycosis fungoides in Italy: Epidemiological impact and diagnostic-therapeutic pathway
2021 S. Alberti Violetti, M. Alaibac, M. Ardigò, A. Baldo, N. Di Meo, C. Massone, F. Onida, G. Simontacchi, I. Zalaudek, N. Pimpinelli, P. Quaglino, E. Berti
Italian expert-based recommendations on the use of photo(chemo)therapy in the management of Mycosis Fungoides: results of an E-Delphi consensus
2021 V. Grandi, A. Baldo, E. Berti, P. Quaglino, S. Rupoli, M. Alaibac, S. Alberti-Violetti, P. Amerio, V. Brazzelli, P.L. Bruni, P. Calzavara-Pinton, A. Parodi, E. Cozzani, M. Burlando, M. Fargnoli, D. Gambini, P. Iacovelli, A. Pacifico, C. Longo, G. Monfrecola, A. Motolese, G. Mozzicafreddo, C. Cota, P. Pigatto, A. Pileri, P. Savoia, M. Simonacci, M. Venturini, A. Offidani, E. Molinelli, M. Pellegrino, E. Trovato, R. Piccinno, K. Lawrence, N. Pimpinelli
The microenvironment’s role in mycosis fungoides and sézary syndrome : From progression to therapeutic implications
2021 A. Pileri, A. Guglielmo, V. Grandi, S.A. Violetti, D. Fanoni, P. Fava, C. Agostinelli, E. Berti, P. Quaglino, N. Pimpinelli
MYCOSIS FUNGOIDES AND SEZARY SYNDROME THE JANUS BIFRONS OF THE CUTANEOUS T-CELL LYMPHOMAS: EVALUATION OF SPECIFIC PHENOTYPE AND GENETIC ALTERATIONS.
2021 S. ALBERTI VIOLETTI